Clinical Trial Technology Editorial

  1. 5 Best Practices For Improving AI Literacy In A GxP Environment 7/25/2025

    ERA Sciences' Ben O'Brien shares five tips to improve pharma and biotech companies' AI literacy when operating in a GxP environment.

  2. Paving The Way For Sites To Use Their Own Tech 7/17/2025

    The DTRA has released a detailed playbook to help clinical research sites use their own validated technology in sponsor-led trials. The "Bring Your Own Technology" (BYOT) model aims to reduce tech overload at sites, improve efficiency, and preserve regulatory compliance — starting with eConsent as its first use case.

  3. More Personalized, Precision Medicine Needed In Psychiatry Clinical Trials 7/16/2025

    Arrivo Bioventures' Joel Raskin, MD, and Greg Rigdon, Ph.D., discuss the importance of personalized and precision medicine in psychiatry clinical trials.

  4. How To Avoid Hazards And Map A Safer, Smarter Path For AI, Part 2 7/15/2025

    The AI journey is full of hidden potholes, unexpected detours, and costly wrong turns. In part two of this series, Tanisha Patel and Vincent Puglia explore more considerations for integrating AI in clinical research.

  5. How To Avoid Hazards And Map A Safer, Smarter Path For AI, Part 1 7/15/2025

    Even with a clear destination with real rewards, the AI journey is full of hidden potholes, unexpected detours, and costly wrong turns. Tanisha Patel and Vincent Puglia explore several considerations when integrating AI in clinical research.

  6. PI's CRAACO Model + AI = Rapid Enrollment 6/30/2025

    At Dr. David Almeida’s clinical trial site in Erie, PA, he practices the CRAACO model exclusively, relying on the revenue he makes from conducting clinical trials for eye-related diseases. To minimize his costs and speed up trial enrollment, he uses a proprietary AI system that has given him an 85% screen-to-enroll ratio.

  7. Breaking Free From The Acronym Soup: Rethinking The Role Of Technology In Clinical Trials 6/30/2025

    Ascendis Pharma's Ivanna Rosendal details how clinical systems hinder clinical trial execution and why we should rethink how technology can support our trials.

  8. 2 Ways To Overcome The Challenge Of Developing Neurological Rare Diseases Drugs 6/16/2025

    GRIN Therapeutics CEO Bruce Leuchter, MD, explores how integrating new business models and technological advances will be crucial to developing new treatments for rare neurological disorders.

  9. Evolving Neurology And Neuroinflammation Therapies And Trials In 2025 6/5/2025

    Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.

  10. In The Age Of AI, Data Is Still King 5/29/2025

    While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D. She explains why proprietary data sets are the foundation of everything AI promises to deliver.